---
title: "Delcath Systems announce first commercial use of Hepzato Kit"
date: "2024-01-17T12:36:42.000Z"
publishedDate: "17 janvier 2024"
summary: "Delcath Systems, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, has announced the first commercial use of Hepzato Kit for the treatment of metastatic uveal melanoma. The procedure took place at Moffitt Cancer Center in Tampa, Florida by Jonathan S Zager, chief academic officer at the facility."
importance: ""
sourceUrl: "https://interventionalnews.com/delcath-systems-announce-first-commercial-use-of-hepzato-kit/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-01-17-delcath-systems-announce-first-commercial-use-of-hepzato-kit"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2023/03/Delcath-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/delcath-systems-announce-first-commercial-use-of-hepzato-kit/"
---

![Delcath Systems announce first commercial use of Hepzato Kit](https://interventionalnews.com/wp-content/uploads/sites/13/2023/03/Delcath-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/delcath-systems-announce-first-commercial-use-of-hepzato-kit/*

## L’essentiel

Delcath Systems, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, has announced the first commercial use of Hepzato Kit for the treatment of metastatic uveal melanoma. The procedure took place at Moffitt Cancer Center in Tampa, Florida by Jonathan S Zager, chief academic officer at the facility.

## Lien source

https://interventionalnews.com/delcath-systems-announce-first-commercial-use-of-hepzato-kit/
